mobile

News

French tech company Kayentis has raised €7 million in private funding that will be invested in its digital platform for clinical trials.

Digital

Heads of innovation, communication and digital strategy in pharma reflected at Frontiers Health 2018 on the implications of technological changes.

News

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in sickle cell disease.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.